黄连温胆汤治疗脾胃湿热型幽门螺旋杆菌阳性浅表性胃炎的疗效观察

目的探讨黄连温胆汤治疗脾胃湿热型幽门螺旋杆菌阳性浅表性胃炎的疗效。方法按照随机数字表法将86例脾胃湿热型幽门螺杆菌(Hp)阳性浅表性胃炎患者均分为试验组和对照组,试验组患者给予黄连温胆汤治疗,对照组患者给予阿莫西林、甲硝唑联合果胶铋治疗,比较两组治疗效果。结果试验组患者痊愈率和治疗总有效率均明显高于对照组,差异具有显著性(P0.05);试验组患者治疗后粘膜有充血、水肿、糜烂、出血点患者的比例均明显低于对照组,差异具有显著性(P0.05);两组患者H.pylori根除率比较,差异无统计学意义(P0.05)。结论黄连温胆汤能够有效改善脾胃湿热型幽门螺旋杆菌阳性浅表性胃炎的临床症状和胃黏膜损伤,临床疗效显著,H.pylori根除效果好,可作为临床治疗优选药物。     

半夏泻心汤加减治疗脾胃湿热型慢性浅表性胃炎患者的价值

目的:探究脾胃湿热型慢性浅表性胃炎治疗应用半夏泻心汤加减的价值。方法:选取2019年1月~2020年6月收治的84例脾胃湿热型慢性浅表性胃炎患者,采取随机数字表法分为参照组和观察组,每组42例。参照组给予常规西药治疗,观察组患者给予半夏泻心汤加减治疗。对比两组患者临床疗效、临床症状积分及不良反应发生情况。结果:观察组临床治疗总有效率为92.86%,高于参照组的73.81%(P<0.05);治疗后,观察组患者嗳气、胃痛、反酸、胃胀等症状积分较参照组低(P<0.05);观察组不良反应发生率低于参照组(P<0.05)。结论:半夏泻心汤加减治疗脾胃湿热型慢性浅表性胃炎,能显著提升临床治疗总有效率,改善患者症状,降低并发症发生率。     

半夏泻心汤加减联合西医治疗幽门螺杆菌感染慢性胃炎的临床疗效观察

目的：探究半夏泻心汤加减联合西医治疗幽门螺杆菌（Hp）感染慢性胃炎的临床疗效。方法：采用随机数字表法将2020年7月至2021年9月收治的Hp感染慢性胃炎患者60例分为对照组和研究组各30例。对照组采用西医治疗；在对照组的基础上，研究组联合半夏泻心汤加减治疗，两组均治疗4周。对比两组临床疗效、中医证候积分、胃蛋白相关指标、Hp根除率及不良反应发生情况。结果：研究组治疗总有效率（93.33%）高于对照组（73.33%），差异有统计学意义（P＜0.05）。相比于对照组，研究组治疗后胃脘疼痛、灼热、恶心呕吐、口苦口臭、大便稀溏等症状评分均更低，胃蛋白酶原Ⅰ、胃蛋白酶原Ⅱ、胃泌素17等胃蛋白酶指标水平也更低，差异有统计学意义（P＜0.05）；研究组Hp根除率高于对照组，差异有统计学意义（P＜0.05）。两组治疗期间均未出现明显不良反应。结论：半夏泻心汤加减联合西医治疗对Hp感染慢性胃炎患者有较好的临床效果，有助于缓解各临床症状，降低胃蛋白酶各指标水平，提升Hp清除率，且无不良反应，安全可靠。     

半夏泻心汤配合中药足浴治疗慢性浅表性胃炎的疗效观察

[目的]观察半夏泻心汤加减配合中药足浴治疗慢性浅表性胃炎的临床疗效。[方法]将68例慢性浅表性胃炎病人随机分为两组,治疗组予半夏泻心汤加减配合中药足浴治疗,对照组予单纯半夏泻心汤加减治疗,两组疗程均为15d,疗程结束后观察两组病人的临床疗效及不良反应。[结果]治疗组总有效率95.0%,对照组总有效率83.3%,两组总有效率比较差异有统计学意义(P0.05)。[结论]半夏泻心汤配合中药足浴治疗慢性浅表性胃炎疗效优于对照组,且安全性好。     

西医三联疗法结合半夏泻心汤加减治疗慢性胃炎患者幽门螺杆菌感染的临床研究

探究西医三联疗法结合半夏泻心汤加减治疗应用于慢性胃炎患者Hp(幽门螺杆菌)感染治疗中的临床效果。选取我院2013年12月~2015年11月慢性胃炎Hp感染患者84例,依据治疗方法不同分为单一组与联合组,各42例。单一组予以西医三联疗法治疗,于此基础上,联合组予以半夏泻心汤加减治疗。观察两组患者Hp根除率、临床效果及不良反应发生率。两组Hp根除率对比,联合组95.2%明显高于单一组76.2%,差异有统计学意义(P0.05);两组总有效率相比,联合组97.6%明显高于单一组78.6%,差异有统计学意义(P0.05);联合组不良反应发生率4.8%明显低于单一组21.4%,差异有统计学意义(P0.05)。对慢性胃炎Hp感染患者予以中西医结合治疗,可明显提高Hp根除率及临床疗效,且安全性较高。     

藿朴夏苓汤加减联合四联疗法治疗幽门螺杆菌相关性胃炎脾胃湿热证临床研究

目的:探索藿朴夏苓汤加减联合四联疗法治疗幽门螺杆菌(HP)相关性胃炎脾胃湿热证临床效果。方法:对我院2013年5月~2015年10月接收的105例幽门螺杆菌相关性胃炎患者,按照随机序号分为对照组52例和观察组53例。对照组采用常规四联疗法治疗,观察组在对照组基础上联合使用藿朴夏苓汤加减治疗,治疗结束后对两组效果进行观察比较。结果:观察组总不良反应发生率为1.9%,低于对照组的3.8%,但两组比较无显著性差异(P0.05)。不良反应未经特殊干预后自行消失,未对患者产生较大的影响。观察组治疗总有效率为96.2%,明显高于对照组的75.0%(P0.05)。观察组患者Hp清除率为94.3%,明显高于对照组的76.9%(P0.05)。结论:藿朴夏苓汤加减联合四联疗法治疗幽门螺杆菌相关性胃炎脾胃湿热证临床效果良好,基本无明显不良反应,且能够明显提高患者的Hp根除率,同时提高治疗效果,因而值得临床借鉴使用。     

藿朴夏苓汤加减治疗脾胃湿热型慢性浅表性胃炎32例临床疗效观察

目的:探讨藿朴夏苓汤加减治疗脾胃湿热型慢性浅表性胃炎的临床意义,旨在确定本中医药治疗方案的临床疗效特点和疗效优势。方法:所有病例随机分治疗组、对照组。治疗组给予藿朴夏苓汤加减,对照组给予施维舒胶囊,8周后复查胃镜及病理。结果:中医证候疗效比较:治疗组总有效率为96.9%,高于对照组78.1%,P<0.01,说明治疗组中医证候改善明显优于对照组;胃镜比较:总有效率治疗组84.4%,对照组75.0%,P>0.05,统计学无显著性差别,但中药治疗组有效率高于西药对照组;病理比较:总有效率治疗组68.8%,对照组65.6%,统计学处理无显著性差异。结论:藿朴夏苓汤加减治疗脾胃湿热型慢性浅表性胃炎中医证候方面疗效确切,胃镜及病理方面同样有其有效性。     

柴芩泻心汤加减治疗肝胃不和型慢性浅表性胃炎临床疗效观察

选取我院80例肝胃不和型慢性浅表性胃炎患者作为研究对象,按照入院时间先后划分为研究组和对照组各40例,分别采用柴芩泻心汤加减治疗和西药多潘立酮治疗,对两组治疗效果进行研究。结果两组患者治疗2个月后,研究组有效率92.5%,高于对照组(72.5%),差异有统计学意义(P0.05)。采用柴芩泻心汤加减治疗肝胃不和型慢性浅表性胃炎,疗效满意,安全可靠,值得进一步扩大应用。     

半夏泻心汤加减治疗功能性消化不良66例临床疗效观察

目的:观察半夏泻心汤加减治疗功能性消化不良的临床疗效。方法:选取2015年10月~2017年7月我院收治的132例功能性消化不良患者为研究对象,随机分为观察组与对照组,各66例。对照组给予吗丁啉治疗,观察组给予半夏泻心汤加减治疗。观察两组患者治疗效果及不良反应发生率。结果:观察组治疗总有效率明显高于对照组(P0.05);两组不良反应发生率比较无明显差异(P0.05)。结论:应用半夏泻心汤加减治疗功能性消化不良效果显著,安全性较高,值得推广。     

半夏泻心汤治疗慢性浅表性胃炎脾胃湿热型疗效观察

目的：探讨半夏泻心汤治疗慢性浅表性胃炎脾胃湿热型的疗效。方法：选取2018年3月~2019年3月收治的96例脾胃湿热型慢性浅表性胃炎患者作为研究对象，以抽签的方式分为观察组和对照组，每组48例。对照组采用三联疗法（奥美拉唑+克拉霉素+阿莫西林）治疗，观察组在三联疗法基础上联合半夏泻心汤治疗。比较两组治疗前后中医症状评分（胃脘胀满、胃脘疼痛、胃脘灼热、口臭口干、纳呆及渴不欲饮）以及幽门螺杆菌清除率。结果：观察组幽门螺杆菌清除率高于对照组（P＜0.05）；治疗后，两组胃脘胀满、胃脘疼痛、胃脘灼热、口臭口干、纳呆及渴不欲饮等中医症状评分均下降，且观察组低于对照组（P＜0.05）。结论：半夏泻心汤联合三联疗法治疗慢性浅表性胃炎脾胃湿热型的效果优于单纯三联疗法。     

Doing more with less and less with more

The "devil is in the details" of any policy response. What forms such changes may take, and what research informs them, are critical to the profession as a whole and to practitioners on a daily basis. Research partnerships between home care agencies and university professors may provide rigorous, systematic, and validated findings necessary for meaningful solutions (Plotkin & Roche, 2000). The evidence of a dialogue between nursing researchers, home healthcare practitioners, and policymakers anticipating impacts on practice of changing fiscal and information-gathering requirements is scant. Such issues are in need a priority discussion by agencies, and collaborative investigative efforts between all involved.     

Communicating with clients and colleagues with hearing loss

Abstract:

Aside from elderly relatives, some of us may have never had any direct personal experience with a person who is deaf or hard of hearing, and so may be unfamiliar with how to effectively communicate with these people. This can make for a very awkward, frustrating and possibly embarrassing experience for both parties. This author is a wearer of hearing aids herself, and would like to share some information on hearing loss and tips on effective communication with a person with hearing loss.     

Mindfulness and Coping with Dysphoric Mood: Contrasts with Rumination and Distraction

Past research has shown that rumination exacerbates dysphoric mood whereas distraction attenuates it. This research examined whether the practice of mindfulness meditation could reduce dysphoric mood even more effectively than distraction. A dysphoric mood was induced in 139 female and 38 male participants who were then randomly assigned to a rumination, distraction, or meditation condition. As predicted, participants instructed to meditate reported significantly lower levels of negative mood than those in either of the two other conditions. Distraction was associated with a lessening of dysphoric mood when compared to rumination but was not as effective as mindfulness meditation. The implications of these findings are discussed.     

Special problems with children and adolescents with diabetes.

Treatment of children and adolescents with insulin-dependent diabetes mellitus (type 1) is different in many ways than it is for adults. Physical, cognitive, and emotional development changes affect therapeutic goals and modalities. Neonatal, early childhood, school-age, and adolescent patients all have unique needs. Further, diabetes can affect psychosocial maturation and the likelihood of difficulties with mood.     

Interaction of peptidoglycans with anti-IgGs and with complement.

This report describes the interaction of peptidoglycan (Streptococcus group A, Staphylococcus epidermidis and Micrococcus lysodeikticus) with 2 serum mediator systems, namely with the anti-IgG system and with complement. The observation that the majority of rabbits hyperimmunized with A-variant streptococcal vaccine produced anti-group carbohydrate antisera containing anti-IgGs and antibodies directed to peptidoglycan suggested that the production of these 2 latter antibodies was related. This view was supported by the finding of a monoclonal 7S anti-IgG with antibody specificity for the pentapeptide of peptidoglycan as evidenced by inhibition of the coprecipitation of 7S anti-IgG with antigen-antibody complexes by the pentapeptide. Inhibition of the anti-idiotype reaction by the pentapeptide provided further evidence for the antibody specificity of 7S anti-IgG for peptidoglycan. When added to normal human sera all peptidoglycan preparations inhibited the hemolytic activity of the sera. Consumption of C3 in C2 deficient serum and consumption of C2 in normal serum indicated the activation of both known complement pathways. Activation of the classical pathway of complement was more efficient since 50 mug of peptidoglycan consumed approximately 70% of C2 per ml normal serum whereas more than 2 mg of the same preparations was required to inactivate 17-24% of C3 in C2 deficient sera. Each of the different peptidoglycan preparations consumed similar amounts of complement in all 20 sera tested. This finding suggested that activation of the classical complement pathway by peptidoglycan was not mediated by anti-peptidoglycan antibodies present in only 20-40% of normal human sera.     

Expanded timed up and go test with subjects with stroke: reliability and comparisons with matched healthy controls

Faria CD, Teixeira-Salmela LF, Silva EB, Nadeau S. Expanded Timed Up and Go test with subjects with stroke: reliability and comparisons with matched healthy controls.ObjectivesTo investigate the intra- and interrater reliabilities of the Expanded Timed Up and Go (ETUG) test with subjects with stroke and to compare the ETUG scores between subjects with stroke and healthy control subjects.DesignCross-sectional.SettingResearch laboratory.ParticipantsStroke participants (n=48; mean age ± SD, 59.29±15.84y) and healthy controls (n=48), matched by age, sex, and levels of physical activity.InterventionsNot applicable.Main Outcome MeasuresThe time spent to complete the ETUG in absolute (s) and ratio values regarding the percentages of the total time. Intraclass correlation coefficients (ICCs), Student t tests, and 95% confidence intervals were employed to investigate the reliability and differences between the groups (α<.05).ResultsBoth intra- and interrater reliabilities showed significant and excellent results for both groups for the absolute values (0.86≤ICC≤1.00; P<.001) and ratio values (0.55≤ICC≤0.99; P<.001). The mean time, in seconds, for all of the ETUG activities was higher for the subjects with stroke than for the control subjects (3.15≤t≤5.78; P<.001). However, when the comparisons considered the ratio values, no significant differences between the groups were found (0.45≤t≤1.15; 0.25≤P≤0.65). These results were confirmed by the 95% confidence interval.ConclusionsSubjects with stroke spent more time in all of the ETUG activities when compared with control subjects. All of the activities appeared to contribute similarly to the poorer performances observed in subjects with stroke, because the ratio values were similar between the groups. Considering the positive intra- and interrater reliability results, the ETUG could be applied to assess the functional mobility of both groups.     

Hemosuccus pancreaticus: diagnosis with CT and MRI and treatment with transcatheter embolization

We report the case of a 56-year-old woman with a presyncopal episode followed by melena. A sentinel clot sign in the pancreatic duct on precontrast computed tomography and the presence of a splenic artery aneurysm on postcontrast computed tomography strongly suggested a fistula between the aneurysm and the duct, as visualized by magnetic resonance imaging. The patient was treated successfully by complete embolization of the splenic artery aneurysm. Received: 25 January 2000/Accepted: 21 February 2001